Newer anticonvulsants in the treatment of anxiety disorders

Simple item page
dc.contributor.authorIpser J.C.
dc.contributor.authorStein D.J.
dc.date.accessioned2011-05-15T16:01:28Z
dc.date.available2011-05-15T16:01:28Z
dc.date.issued2006
dc.description.abstractThis is the protocol for a review and there is no abstract. The objectives are as follows: 1) To use evidence from RCTs in providing an estimate of the overall effects of the newer anticonvulsants in improving treatment response and reducing symptom severity in the treatment of anxiety disorders. 2) To determine whether particular anticonvulsants are more effective and tolerable than others in the treatment of anxiety disorders. 3) To determine whether the particular anxiety disorder treated predicts the effectiveness of anticonvulsants in terms of efficacy and tolerability. 4) To identify which factors (clinical, methodological) predict response to pharmacotherapy. Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
dc.description.versionReview
dc.identifier.citationCochrane Database of Systematic Reviews
dc.identifier.citation4
dc.identifier.issn1469493X
dc.identifier.other10.1002/14651858.CD006241
dc.identifier.urihttp://hdl.handle.net/10019.1/11992
dc.subjectanticonvulsive agent
dc.subjectetiracetam
dc.subjectfelbamate
dc.subjectgabapentin
dc.subjectlamotrigine
dc.subjectoxcarbazepine
dc.subjectplacebo
dc.subjectpregabalin
dc.subjecttiagabine
dc.subjecttopiramate
dc.subjectvigabatrin
dc.subjectzonisamide
dc.subjectanxiety disorder
dc.subjectaplastic anemia
dc.subjectclinical protocol
dc.subjectclinical trial
dc.subjectCochrane Library
dc.subjectdata extraction
dc.subjectdata synthesis
dc.subjectdisease severity
dc.subjectdizziness
dc.subjectdrug effect
dc.subjectdrug efficacy
dc.subjectdrug tolerability
dc.subjecthuman
dc.subjectinformation processing
dc.subjectintervention study
dc.subjectliver toxicity
dc.subjectMEDLINE
dc.subjectmeta analysis
dc.subjectmethodology
dc.subjectObsessive-compulsive disorderen_ZA
dc.subjectoutcome assessment
dc.subjectpsychosis
dc.subjectpublishing
dc.subjectrandomization
dc.subjectrash
dc.subjectreview
dc.subjectrisk factor
dc.subjectsensitivity analysis
dc.subjectsomnolence
dc.subjectStevens Johnson syndrome
dc.subjectsystematic review
dc.subjecttoxic epidermal necrolysis
dc.subjecttreatment outcome
dc.subjecttreatment response
dc.subjectvisual field defect
dc.titleNewer anticonvulsants in the treatment of anxiety disorders
dc.typeReview
Files
Collections
Stellenbosch University - Scopus Publications